Skip to content
HowShorted

Prestige Consumer Healthcare Inc. short interest in 2019

In 2019, Prestige Consumer Healthcare Inc.'s disclosed short interest ran from 20.62% of shares outstanding on 15 Jan 2019 to 18.25% on 31 Dec 2019, a change of -2.37 percentage points. The year's high was 21.50% on 31 May 2019 and its low 18.25% on 31 Dec 2019, averaging 20.05% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 43.24 days on 29 Nov 2019. Full history: Prestige Consumer Healthcare Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Prestige Consumer Healthcare Inc. in 2019

2019 in figures

Start of year
20.62% (15 Jan 2019)
End of year
18.25% (31 Dec 2019)
Change
-2.37 pp
High
21.50% (31 May 2019)
Low
18.25% (31 Dec 2019)
Average
20.05%
Highest days to cover
43.24 (29 Nov 2019)
SEC filings marked
9

Every report in 2019

Prestige Consumer Healthcare Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201920.62%16.16results (8-K)
31 Jan 201920.12%18.93
15 Feb 201920.11%15.6910-Q filed, results (8-K)
28 Feb 201919.47%20.96
15 Mar 201920.51%21.54
29 Mar 201921.40%22.68
15 Apr 201920.71%15.76
30 Apr 201919.55%27.33
15 May 201920.20%20.11results (8-K), 10-K filed
31 May 201921.50%33.04
14 Jun 201919.73%27.04
28 Jun 201920.28%23.94
15 Jul 201920.34%24.56
31 Jul 201920.84%24.92
15 Aug 201920.43%23.7510-Q filed, results (8-K)
30 Aug 201920.72%35.43
13 Sep 201920.90%22.85
30 Sep 201920.24%22.64
15 Oct 201919.76%31.46
31 Oct 201919.02%34.1710-Q filed, results (8-K)
15 Nov 201918.98%29.93
29 Nov 201918.91%43.24
13 Dec 201918.66%31.26
31 Dec 201918.25%31.92

See also: Prestige Consumer Healthcare Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.